Get started
MAYNE PHARMA GROUP LIMITEDMAYNE PHARMA GROUP LIMITEDMAYNE PHARMA GROUP LIMITED

MAYNE PHARMA GROUP LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

MYX chart

Key stats

Market capitalization
‪578.51 M‬AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.93AUD
Net income
‪−316.42 M‬AUD
Revenue
‪183.59 M‬AUD
Shares float
‪61.54 M‬
Beta (1Y)
−0.08

About MAYNE PHARMA GROUP LIMITED

Sector
Health Technology
CEO
Shawn Patrick O'Brien
Headquarters
Salisbury
Website
maynepharma.com
Founded
2005
ISIN
AU000000MYX0
FIGI
BBG000BLN6N6
Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Products, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment is involved in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty Products segment includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment manufactures and sells branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MYX is 6.75 AUD — it has increased by 1.35% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange MAYNE PHARMA GROUP LIMITED stocks are traded under the ticker MYX.
MAYNE PHARMA GROUP LIMITED is going to release the next earnings report on Aug 23, 2024. Keep track of upcoming events with our Earnings Calendar.
MYX stock is 2.58% volatile and has beta coefficient of −0.08. Check out the list of the most volatile stocks — is MAYNE PHARMA GROUP LIMITED there?
One year price forecast for MAYNE PHARMA GROUP LIMITED has a max estimate of 7.38 AUD and a min estimate of 6.69 AUD.
MYX earnings for the last quarter are −2.01 AUD whereas the estimation was −0.57 AUD which accounts for −251.75% surprise. Estimated earnings for the next quarter are −0.46 AUD. See more details about MAYNE PHARMA GROUP LIMITED earnings.
MAYNE PHARMA GROUP LIMITED revenue for the last quarter amounts to ‪82.40 M‬ AUD despite the estimated figure of ‪173.00 M‬ AUD. In the next quarter revenue is expected to reach ‪161.00 M‬ AUD.
Yes, you can track MAYNE PHARMA GROUP LIMITED financials in yearly and quarterly reports right on TradingView.
MYX stock has fallen by 4.93% compared to the previous week, the month change is a 0.88% fall, over the last year MAYNE PHARMA GROUP LIMITED has showed a 69.17% increase.
MYX net income for the last quarter is ‪−70.55 M‬ AUD, while the quarter before that showed ‪−171.84 M‬ AUD of net income which accounts for 58.94% change. Track more MAYNE PHARMA GROUP LIMITED financial stats to get the full picture.
Today MAYNE PHARMA GROUP LIMITED has the market capitalization of ‪566.60 M‬, it has decreased by 1.10% over the last week.
Like other stocks, MYX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MAYNE PHARMA GROUP LIMITED stock right from TradingView charts — choose your broker and connect to your account.
MYX reached its all-time high on Aug 15, 2016 with the price of 42.20 AUD, and its all-time low was 2.68 AUD and was reached on Feb 8, 2023.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MAYNE PHARMA GROUP LIMITED technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MAYNE PHARMA GROUP LIMITED stock shows the neutral signal. See more of MAYNE PHARMA GROUP LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MAYNE PHARMA GROUP LIMITED future price: according to them, MYX price has a max estimate of 7.38 AUD and a min estimate of 6.69 AUD. Read a more detailed MAYNE PHARMA GROUP LIMITED forecast: see what analysts think of MAYNE PHARMA GROUP LIMITED and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MAYNE PHARMA GROUP LIMITED EBITDA is ‪−30.87 M‬ AUD, and current EBITDA margin is −65.91%. See more stats in MAYNE PHARMA GROUP LIMITED financial statements.